Interleukin-10 Improves Outcome and Alters Proinflammatory Cytokine Expression after Experimental Traumatic Brain Injury

This publication has 46 references indexed in Scilit:

• Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes
  FEBS Letters, 1996
• Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window
  Brain Research, 1995
• Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
  European Journal of Immunology, 1994
• Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.
  The Journal of Experimental Medicine, 1994
• The Early Reactions of Non-Neuronal Cells to Brain Injury
  Annual Review of Neuroscience, 1994
• Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.
  Journal of Clinical Investigation, 1994
• Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-? in the rat
  Journal of Neuro-Oncology, 1994
• Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
  The Journal of Experimental Medicine, 1993
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976